Montelukast Prescribing at MARSDEN MEDICAL GROUP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
2,283
Total Quantity
81.1K
NHS Cost
£4.1K
vs National Avg
+233.4%
MARSDEN MEDICAL GROUP prescribed 2,283 items of Montelukast over the last 12 months at a cost of £4,103 to the NHS. This is 233.4% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
179
Jul 2026
174
Jul 2026
177
Jul 2026
199
Jul 2026
218
Jul 2026
193
Jul 2026
171
Jul 2026
197
Jul 2026
202
Jul 2026
170
Jul 2026
186
Jul 2026
217
Prescribing Details
| Total Items | 2,283 |
|---|---|
| Total Quantity | 81,135 |
| Total NHS Cost | £4,103 |
| Presentations | 4 different forms |
| vs National Average | +233.4% |
Montelukast Prescribing Comparison
| This practice | 2,283 items |
|---|---|
| National average per practice | 685 items |
| Difference | +233.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.